Key result
Mitral transcatheter edge-to-edge repair (M-TEER) is a safe and effective therapy for severe mitral regurgitation in patients at high surgical risk.
Why the study?
To provide updated evidence in the field of M-TEER from its inception, focusing on clinical and anatomical features for proper patient and device selection.
M-TEER is a safe and effective therapy for severe mitral regurgitation in high surgical risk patients, with expanding indications due to improved devices and operator experience.
Encourages M-TEER referral to experienced centers; leaves open optimal device selection for broader populations.
INTRODUCTION: Over the last two decades, mitral transcatheter edge-to-edge repair (M-TEER) has become a safe and effective therapy for severe mitral regurgitation in patients deemed at high surgical risk. AREAS COVERED: This review aims to encompass the most relevant and updated evidence in the field of M-TEER from its inception, focusing on clinical and anatomical features for proper patient and device selection. EXPERT OPINION: Growing operator experience and device iterations have resulted in improved clinical outcomes and an expansion of the therapy to patients with complex anatomies and clinical scenarios. Future investigations are warranted to determine the best management options and the most suitable device for every patient with MR.
No takes yet. Share an insight, caveat, or question.
van-Roessel et al. (2023) conducted a review in severe mitral regurgitation. mitral transcatheter edge-to-edge repair (M-TEER) was evaluated. Mitral transcatheter edge-to-edge repair (M-TEER) is a safe and effective therapy for severe mitral regurgitation in patients at high surgical risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: